Precigen PGEN
NASDAQ PGEN
$7.11 -0.03 (-0.49%)
As of: Sep 4, 2026 · 3:58 PM EDT

Precigen (PGEN) Current Leases (2012 - 2026)

Precigen (PGEN) posted quarterly Current Leases of $1.1 million for Q1 2026, up 15.09% year-over-year from $928000.0 in Q1 2025, and down 5.99% quarter-over-quarter from $1.1 million in Q4 2025.

Analysis

Precigen (PGEN) Current Leases (2012 - 2026) Analysis & Trends

Precigen (PGEN) has reported Current Leases for 10 consecutive years, with $1.1 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Current Leases rose 15.09% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $1.1 million (up 15.09% YoY), while the FY2025 annual figure was $1.1 million, up 18.83% from the prior year.
  • Current Leases fell to $1.1 million in Q1 2026 per PGEN's latest filing, from $1.1 million in the prior quarter.
  • Across five years, Current Leases topped out at $1.6 million in Q1 2022 and bottomed at $928000.0 in Q1 2025.
  • Historically, Current Leases has averaged $1.2 million across 5 years, with a median of $1.1 million in 2025.
  • Annual changes were most pronounced in 2022 — Current Leases sank 46.86% — and 2023, when it surged 37.56%.
  • Precigen's Current Leases stood at $1.2 million in 2022, then fell by 0.58% to $1.2 million in 2023, then fell by 20.47% to $956000.0 in 2024, then grew by 18.83% to $1.1 million in 2025, then dropped by 5.99% to $1.1 million in 2026.
  • Business Quant data shows PGEN's Current Leases at $1.1 million in Q1 2026, $1.1 million in Q4 2025, and $1.1 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 720.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 11.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 16.75 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 21.95 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 45.93 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.27 Mn
10 Precigen 2.53 Bn 2.53 Bn 52.17 Mn 1.06 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.06 Mn
Mar 31, 2026 1.07 Mn
Dec 31, 2025 1.14 Mn
Sep 30, 2025 1.12 Mn
Jun 30, 2025 930,000.00
Mar 31, 2025 928,000.00
Dec 31, 2024 956,000.00
Sep 30, 2024 988,000.00
Jun 30, 2024 1.27 Mn
Mar 31, 2024 1.32 Mn
Dec 31, 2023 1.20 Mn
Sep 30, 2023 1.20 Mn
Jun 30, 2023 1.42 Mn
Mar 31, 2023 1.24 Mn
Dec 31, 2022 1.21 Mn
Sep 30, 2022 1.04 Mn
Jun 30, 2022 1.03 Mn
Mar 31, 2022 1.59 Mn
Dec 31, 2021 1.39 Mn
Sep 30, 2021 1.96 Mn